Seuraa
Lynne Wagenknecht
Lynne Wagenknecht
Professor of Epidemiology,Wake Forest School of Medicine
Vahvistettu sähköpostiosoite verkkotunnuksessa wakehealth.edu
Nimike
Viittaukset
Viittaukset
Vuosi
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
GB Ehret, PB Munroe, KM Rice, M Bochud, AD Johnson, DI Chasman, ...
Nature 478 (7367), 103, 2011
23252011
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
E Selvin, MW Steffes, H Zhu, K Matsushita, L Wagenknecht, J Pankow, ...
New England Journal of Medicine 362 (9), 800-811, 2010
21442010
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes
RR Wing, W Lang, TA Wadden, M Safford, WC Knowler, AG Bertoni, ...
Diabetes care 34 (7), 1481-1486, 2011
21252011
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
EJ Mayer-Davis, JM Lawrence, D Dabelea, J Divers, S Isom, L Dolan, ...
New England Journal of Medicine 376 (15), 1419-1429, 2017
18002017
Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study
G Howard, LE Wagenknecht, GL Burke, A Diez-Roux, GW Evans, ...
Jama 279 (2), 119-124, 1998
11421998
Association of an intensive lifestyle intervention with remission of type 2 diabetes
EW Gregg, H Chen, LE Wagenknecht, JM Clark, LM Delahanty, J Bantle, ...
Jama 308 (23), 2489-2496, 2012
8482012
The Insulin Resistance Atherosclerosis Study
AJG Hanley, K Williams, A Festa, LE Wagenknecht, RB D’Agostino Jr, ...
DIABETES 54, 2005
710*2005
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study
AJG Hanley, K Williams, A Festa, LE Wagenknecht, RB D’Agostino, ...
Diabetes 54 (11), 3140-3147, 2005
6182005
Association between midlife vascular risk factors and estimated brain amyloid deposition
RF Gottesman, ALC Schneider, Y Zhou, J Coresh, E Green, N Gupta, ...
Jama 317 (14), 1443-1450, 2017
6092017
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study.
L Mykkänen, DJ Zaccaro, LE Wagenknecht, DC Robbins, M Gabriel, ...
Diabetes 47 (5), 793-800, 1998
5051998
Microalbuminuria (mab) is Associated with Insulin Resistance in Nondiabetic Subjects
L Mykkanen, L Wagenknecht, D Zaccaro, S Haffner
Diabetes 45 (2S), 192A, 1996
504*1996
Microalbuminuria (mab) is Associated with Insulin Resistance in Nondiabetic Subjects: The Insulin Resistance Atherosclerosis Study
L Mykkanen, L Wagenknecht, D Zaccaro, S Haffner
Diabetes 45 (2S), 192A, 1996
5041996
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
C Pattaro, A Teumer, M Gorski, AY Chu, M Li, V Mijatovic, M Garnaas, ...
Nature communications 7, 10023, 2016
5022016
Diabetes in midlife and cognitive change over 20 years: a cohort study
AM Rawlings, AR Sharrett, ALC Schneider, J Coresh, M Albert, D Couper, ...
Annals of internal medicine 161 (11), 785-793, 2014
5002014
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study
AJG Hanley, K Williams, A Festa, LE Wagenknecht, RB D’Agostino, ...
Diabetes 53 (10), 2623-2632, 2004
4982004
Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study
L Palaniappan, MR Carnethon, Y Wang, AJG Hanley, SP Fortmann, ...
Diabetes Care 27 (3), 788-793, 2004
4842004
Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels.
LE Wagenknecht, GL Burke, LL Perkins, NJ Haley, GD Friedman
American Journal of Public Health 82 (1), 33-36, 1992
4671992
Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study
LE Wagenknecht, CD Langefeld, AL Scherzinger, JM Norris, SM Haffner, ...
Diabetes 52 (10), 2490-2496, 2003
4492003
Twenty-two year trends in incidence of myocardial infarction, CHD mortality, and case-fatality in four US communities, 1987 to 2008
WD Rosamond, LE Chambless, G Heiss, TH Mosley, J Coresh, E Whitsel, ...
Circulation, CIRCULATIONAHA. 111.047480, 2012
443*2012
Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes
M Lazo, SF Solga, A Horska, S Bonekamp, AM Diehl, FL Brancati, ...
Diabetes care 33 (10), 2156-2163, 2010
4382010
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20